Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K. Sicklick(University of California San Diego), Shumei Kato(University of California San Diego), Ryosuke Okamura(University of California San Diego), Maria Schwaederlé(University of California San Diego), Michael E. Hahn(University of California San Diego), Casey Williams(Avera Health), Pradip De(Avera Health), Amy Krie(Avera Health), David Piccioni(University of California San Diego), Vincent A. Miller(Foundation Medicine (United States)), Jeffrey S. Ross(SUNY Upstate Medical University), Adam Benson, Jennifer Webster(Foundation Medicine (United States)), Philip J. Stephens(Menlo School), J. Jack Lee(The University of Texas MD Anderson Cancer Center), Paul T. Fanta(University of California San Diego), Scott M. Lippman(University of California San Diego), Brian Leyland‐Jones(Avera Health), Razelle Kurzrock(University of California San Diego)
Cited by 710Open Access